Welcome to Global Good’s Impact Interview series. This interview series is designed to tell the stories of the people and companies working to drive impact in society.
Can you introduce yourself and tell us about your role?
I’m Rania Maklad, Co-Founder and CEO of Ocuwell, a MedTech company focused on transforming eye care through portable, affordable, and cloud-enabled corneal diagnostic solutions. At Ocuwell, I lead the company’s vision and strategy, working closely with our technical, clinical, and product teams to translate years of ocular research into practical tools that deliver clinical-grade performance outside traditional hospital settings. My role is centred on ensuring that our technology remains precise, ethical, and accessible, with a strong focus on expanding quality eye care to underserved and remote communities without compromising diagnostic accuracy.
How did your company come about and what was the motivation behind it?
Ocuwell was created to address a very real and urgent gap in eye care: despite the widespread burden of corneal disorders globally, traditional diagnostic and treatment tools remain expensive, bulky, and largely confined to specialised clinics. This leaves many people without timely access to quality eye health assessment and care. Ocuwell was founded in 2022 to transform this reality by developing portable, affordable, cloud-enabled corneal diagnostic solutions that deliver clinical-grade performance outside traditional hospital settings, bringing precise eye care closer to patients wherever they are.
Built on decades of research in ocular biomechanics and imaging, our technology was designed to bridge the divide between high-quality diagnostics and accessibility, enabling better early detection, personalised care planning, and improved outcomes without sacrificing precision.
Can you describe your company’s mission and values?
Ocuwell’s mission is to democratise access to quality eye care by transforming corneal diagnostics with portable, affordable, and cloud-enabled solutions that deliver clinical-grade performance outside traditional hospital settings. Our goal is to make precision eye health assessment reachable for all — including underserved and remote communities — without sacrificing diagnostic quality.
Our core values guide everything we do:
• Innovation — creating simple solutions to complex eye-care challenges.
• Empowerment — giving patients the tools to manage and understand their sight.
• Precision — considering every detail to deliver clinical excellence.
• Accessibility — ensuring healthy sight is afforded by all.
• Passion — driven by a commitment to improving lives.
What are some of the most pressing social issues that your company is working to address through its technology?
Ocuwell is addressing the global lack of access to quality eye care, particularly in underserved, remote, and low-resource communities. Many people experience preventable vision loss because accurate corneal diagnostics are expensive, centralised, and confined to specialised clinics and hospitals. Ocuwell’s technology enables portable, affordable, and cloud-enabled corneal diagnostics for use in primary care settings, allowing eye conditions to be identified earlier and closer to patients. This leads to faster, more efficient care, improves early intervention, and reduces unnecessary referrals, easing pressure on secondary care services and hospitals. By delivering clinical-grade precision beyond traditional hospital settings, Ocuwell works to improve patient outcomes, strengthen healthcare systems, and expand equitable access to eye health.
How does your company measure the impact of its work in creating positive change?
Ocuwell measures its impact by focusing on both clinical outcomes and system-level improvements in access to eye care. We evaluate how effectively our technology enables accurate corneal assessment outside traditional hospital settings, particularly within primary care and underserved environments. Key indicators include earlier detection of corneal conditions, improved referral efficiency, and reduced reliance on secondary care services. We also assess adoption by healthcare providers, usability in real-world settings, and consistency of clinical-grade performance. By tracking how our solutions expand access to quality eye care while maintaining precision and supporting more efficient healthcare delivery, we ensure our work is creating meaningful, measurable, and long-term positive change.
In your opinion, what impact will technology have in creating a better future?
Technology has the potential to create a better future when it is designed with purpose, responsibility, and human needs at its core. When applied thoughtfully, it can expand access to essential services like healthcare, reduce inequalities, and enable earlier, more efficient interventions that improve quality of life. In health in particular, technology can shift care closer to people by moving diagnostics and decision-making into primary and community settings, easing pressure on overstretched systems. However, positive impact is not driven by innovation alone—it requires precision, ethics, and accountability. The greatest value of technology lies in its ability to empower individuals and professionals with reliable tools that deliver real-world outcomes while strengthening systems for the long term.
What advice do you have for other companies looking to use tech for good and positively impact the world?
Companies looking to use technology for good should start by deeply understanding the real problems they aim to solve, especially from the perspective of the people and systems affected. Impact comes from building solutions that are useful, trustworthy, and grounded in evidence—not from technology for its own sake. It’s essential to prioritise ethics, precision, and long-term outcomes, particularly in healthcare, where trust and quality are critical. Affordability and scale should never come at the expense of accuracy or responsibility. Finally, meaningful impact requires collaboration with clinicians, communities, and partners, and a commitment to measuring outcomes over time to ensure that innovation is truly improving lives and strengthening systems.
Ocuwell is part of the Super Connect Series, powered by Empact Ventures and sponsored by CTO in Your Pocket, created by Novidian, who work closely with Rania and the team
